The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 25, 2018

Filed:

Sep. 29, 2014
Applicants:

Jean-claude Lecron, Bonnes, FR;

Hughes Gascan, Angers, FR;

Franck Morel, Savigney l'Evescault, FR;

Sylvie Chevalier, Angers, FR;

Francois-xavier Bernard, Saint Maurice la Clouere, FR;

Katia Boniface, Mountain View, CA (US);

Caroline Diveau, Palo Alto, CA (US);

Inventors:

Jean-Claude Lecron, Bonnes, FR;

Hughes Gascan, Angers, FR;

Franck Morel, Savigney l'Evescault, FR;

Sylvie Chevalier, Angers, FR;

Francois-Xavier Bernard, Saint Maurice la Clouere, FR;

Katia Boniface, Mountain View, CA (US);

Caroline Diveau, Palo Alto, CA (US);

Assignees:

Universite D'Angers, Angers, FR;

Universite de Poitiers, Poitiers, FR;

Bioalternatives SAS, Gencay, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/19 (2006.01); A61K 38/20 (2006.01); A61K 38/17 (2006.01); A61K 38/21 (2006.01); A61K 8/64 (2006.01); A61Q 19/00 (2006.01); C07K 16/28 (2006.01); C12N 5/071 (2010.01);
U.S. Cl.
CPC ...
A61K 38/2006 (2013.01); A61K 8/64 (2013.01); A61K 38/1793 (2013.01); A61K 38/20 (2013.01); A61K 38/204 (2013.01); A61K 38/217 (2013.01); A61Q 19/00 (2013.01); C07K 16/28 (2013.01); C12N 5/0629 (2013.01); C07K 2317/76 (2013.01); C12N 2501/2306 (2013.01);
Abstract

The invention disclosed herein relates to the field of epidermal repair and skin innate immunity. More particularly, the invention concerns the use of a mix of cytokines to inhibit keratinocyte differentiation, activate skin innate immunity, increase the expression of anti-microbial peptides, and improve epidermal repair. In particular, the invention concerns compositions comprising at least IL-17, TNFα and OSM that can be formulated for topical administration for cosmetic or dermatologic use.


Find Patent Forward Citations

Loading…